In the setting of diabetes or metabolic syndrome, factors like insulin resistance, chronic low-grade inflammation, and oxidative stress may change baseline FSTL1 levels and even the direction of its downstream effects. The gene discussed is FSTL1; the disease is diabetes mellitus.